You are here: Home / Protocols / Liver Rapid Reference Set Application: Gary Norman-INOVA (2012)
Team Project

Liver Rapid Reference Set Application: Gary Norman-INOVA (2012)

356
Norman, Gary L.INOVA Diagnostics Inc.
Feng, ZidingFred Hutchinson Cancer Research Center
Golgi protein 73 (GP73), also known as Golgi membrane protein 1 (Golm1) or Golgi phosphoprotein 2 (Golph2),
Proteomics
G.I. and Other Associated Cancers Research Group

We have developed a new and novel assay for the detection of Golgi protein 73 (GP73), also known as Golgi membrane protein 1 (Golm1) or Golgi phosphoprotein 2 (Golph2), in serum/plasma. The clinical question is to determine the clinical utility of gp73 antigen detection by the new assay for early hepatocullular carcinoma (HCC) diagnosis, for risk-assessment of patients at high risk for progression of their liver disease, and for prognosis.

The EDRN reference set will provide us with an opportunity to test the present version of the assay on a new, well-characterized cohort that has not been subjected to multiple freeze/thaw cycles.
Since this assay will be submitted to the FDA for 510(k) clearance, we will want to test a training set prior to the blinded test set. Statistical analysis will be conducted at the DMCC.

No datasets are currently associated with this protocol.


🔜 Data-Sci Workshop
The EDRN Biomarker Data Science Workshop is coming this August, 2020. More details available soon.
Announcement 03/17/2020

The EDRN Registration page will be available soon to register for the 35th EDRN Steering Committee Meeting, now scheduled to take place from June 30-July 2, 2020, in Tempe, AZ.
Announcement



 
This icon signifies that something is happening and we kindly ask you to please wait